Penyakit Mata Kering
DOI:
https://doi.org/10.55175/cdk.v45i3.817Keywords:
Penyakit mata kering, tear filmAbstract
Penyakit mata kering (PMK) adalah penyakit multifaktorial air mata dan permukaan mata dengan gejala tidak nyaman, gangguan penglihatan, dan ketidakstabilan tear film yang berpotensi merusak permukaan mata. Sekitar 5%-34% penduduk di dunia menderita mata kering, angka kejadiannya meningkat seiring usia. Penyakit mata kering diklasifikasikan berdasarkan etiopatologinya, yaitu mata kering defisiensi aqueous (MKDA) dan mata kering evaporasi (MKE). Gejala mata kering dapat menurunkan kualitas hidup, meningkatkan gejala depresi, dan gangguan mood. Terapi terbatas mengurangi gejala.
Dry eye disease (DED) is a multifactorial disease of the tears and ocular surface resulting in dyscomfort, visual disturbance, and tear film instability with potential ocular surface damage. The world prevalence is 5-34 %, its incidence increases significantly with age. DED is classified to aqueous deficient dry eye (ADDE) and evaporate dry eye (EDE). Its symptom have been associated with reduced quality of life, increased depressive symptoms, and mood disorders.
Downloads
References
Tear Film & Ocular Surface Society. 2007 Report of the international dry eye syndrome. Ocular Surface 2007;5(2):59-200.
Phadatare SP, Momin M, Nighojkar P, Askarkar S, Singh KK. A comprehensive review on dry eye disease: Diagnosis, medical management, recent developments, and future challenges. Advances in Pharmaceutics 2015;1-13.
Stapleton F, Garrett Q, Chan C, Craig JP. The epidemiology of dry eye disease. In: Chan C, editor. Dry eye: A practical approach, essentials in ophthalmology. Berlin: Springer-Verlag; 2015.
Munir SZ, Aylward J. A review of ocular graft-versus-host disease. Ophtometry and Vision Science 2017;94(5):1-11.
Messmer EM. The pathophysiology, diagnosis and treatment of dry eye disease. Dtsch Arztebl Int. 2015;112:71-82.
Tsubota K, Yokoi N, Shimazaki J, Watanabe H, Dogru M, Yamada M, et al. New perspectives on dry eye definition and diagnosis: A consensus report by the Asia dry eye society. The Ocular Surface 2017;15(1):65-76.
Baudouin C, Aragona P, Setten GV, Rolando M, Irkeç M, Benítez del Castillo J, et al. Diagnosing the severity of dry eye: A clear and practical algorithm. Br J Ophthalmol. 2014;98(9):1168-76. doi: 10.1136/bjophthalmol-2013-304619.
Gulati S, Jain S. Ocular pharmacology of tear film, dry eye, and allergic conjunctivitis in handbook of experimental pharmacology. Springer; 2016.
Sambursky R. Presence or absence of ocular surface inflammation directs clinical and therapeutic management of dry eye. Clin Ophthalmol. 2016;10:2337-44.
Li Y, Cui L, Lee HS, Kang YS, Choi W, Yoon KC. Comparison of 0.3% hypotonic and isotonic sodium hyaluronate eye drops in the treatment of experimental dry eye. Curr Eye Res. 2017;42(8):1108-14. doi: 10.1080/02713683.2017.1297462.
Hori Y, Kageyama T, Sakamoto A, Shiba T, Nakamura M, Maeno T. Comparison of short-term effects of diquafosol and rebamipide on mucin 5AC level on the rabbit ocular surface. J Ocul Pharmacol Ther. 2017;33(6):493-7. doi: 10.1089/jop.2016.0092.
Fukuoka S, Arita R. Increase in tear film lipid layer thickness after instillation of 3% diaquafosol ophthalmic solution in healthy human eyes. Ocul Surf. 2017;15(4):730-5. doi: 10.1016/j.jtos.2017.03.005.
Basak SK. Dry eye disease. All India Ophthalmol Soc [Internet]. 2014. Available from: http://www.aios.org/cme/pppseries1.pdf
Milner MS, Beckman KA, Luchs JI, Allen QB, Awdeh RM, Berdahl J, et al. Dysfunctional tear syndrome: Dry eye disease and associated tear film disorders – New strategies for diagnosis and treatment. Curr Opin Ophthalmol. 2017;27(Suppl 1):3-47. doi: 10.1097/01.icu.0000512373.81749.b7.
Pan Q, Angelina A, Zambrano A, Marrone M, Stark WJ, Heflin T, et al. Autologous serum eye drops for dry eye. Cochrane Database Syst Rev. 2013;(8):CD009327. doi: 10.1002/14651858.CD009327.pub2
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 https://creativecommons.org/licenses/by-nc/4.0/
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
